V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210036789 | 210009326 | 1.75 | 84.3 | Curative (C) | 2018-02-22 | 2018-06-09 | HYDROCORTISONE IT + METHOTREXATE IT | Y | N | 210018380 | METHOTREXATE |
| 210036790 | 210009328 | 1.85 | 68.6 | Curative (C) | 2017-04-27 | 2019-01-21 | ALL UKALL2003 TRIAL | 02 | N | 210018384 | UKALL 2003 |
| 210036791 | 210009338 | 0 | 78.6 | Palliative (P) | 2014-01-28 | 2014-02-19 | IDELALISIB + RITUXIMAB | 2 | N | 210018415 | IDELALISIB + RITUXIMAB |
| 210036792 | 210009364 | 1.59 | null | Adjuvant (A) | 2017-02-26 | 2017-12-09 | Imatinib 600mg | 01 | N | 210018484 | IMATINIB |
| 210036794 | 210030811 | 1.71 | 66 | Curative (C) | 2018-03-29 | 2018-03-29 | ALL UKALL2003 B: Ph VII Maintenance | 01 | N | 210018518 | UKALL 2003 |
| 210036795 | 210009385 | 1.59 | 80 | Curative (C) | 2017-11-22 | 2017-12-26 | IDELALISIB + RITUXIMAB | 2 | N | 210018557 | IDELALISIB + RITUXIMAB |
| 210036796 | 210009393 | 1.79 | 57.6 | Palliative (P) | 2016-11-02 | 2016-12-16 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 210018577 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210036797 | 210009396 | 1.69 | 70 | Curative (C) | 2017-03-27 | 2017-03-27 | Triple Intrathecal | 2 | N | 210018579 | TRIPLE INTRATHECAL |
| 210036798 | 210009415 | 1.73 | 60 | Curative (C) | 2016-11-11 | 2016-11-11 | CHLORAMBUCIL + OBINUTUZUMAB | Y | N | 210018654 | CHLORAMBUCIL + OBINUTUZUMAB |
| 210036799 | 210009436 | null | null | Curative (C) | 2017-05-24 | 2017-09-15 | ALL Int GdeC D Int PhIV recon Pasp | N | null | 210018723 | ALL INTENSIFICATION |
| 210036801 | 210009726 | 1.86 | 93.5 | Palliative (P) | 2016-08-30 | 2016-08-30 | Etoposide Conditioning | N | N | 210019671 | ETOPOSIDE |
| 210036802 | 210009734 | 1.66 | 69.8 | Curative (C) | null | 2017-09-04 | MERCAPTOPURINE + METHOTREXATE | Y | N | 210019691 | MERCAPTOPURINE + METHOTREXATE |
| 210036803 | 210010041 | 1.2 | 102.6 | Curative (C) | 2017-11-12 | 2019-10-02 | Venetoclax | Y | N | 210020804 | VENETOCLAX |
| 210036804 | 210010082 | 1.86 | 71.4 | Curative (C) | 2015-11-27 | 2017-04-08 | Etoposide oral | N | N | 210020935 | ETOPOSIDE |
| 210036805 | 210010087 | null | 55.8 | Palliative (P) | 2013-09-03 | 2015-06-26 | Etoposide Conditioning | N | N | 210020956 | ETOPOSIDE |
| 210036806 | 210010130 | 1.68 | 19.6 | Neo-adjuvant (N) | 2017-01-27 | 2017-01-27 | Blinatumomab | N | Y | 210021134 | BLINATUMOMAB |
| 210036807 | 210020511 | null | 131 | Disease modification (D) | 2016-03-10 | 2016-03-30 | MERCAPTOPURINE + METHOTREXATE | N | N | 210021185 | MERCAPTOPURINE + METHOTREXATE |
| 210036808 | 210010191 | null | 80 | Curative (C) | 2018-09-27 | 2019-03-05 | Alemtuz+Fludara+Melphalan RIC MUD | N | Y | 210021334 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036809 | 210020555 | 1.72 | 29.6 | Curative (C) | 2015-11-09 | 2017-02-08 | MERCAPTOPURINE + METHOTREXATE | Y | null | 210021343 | MERCAPTOPURINE + METHOTREXATE |
| 210036810 | 210010240 | 1.63 | 20.8 | Disease modification (D) | 2018-08-22 | 2019-04-30 | Mercaptopurine | N | N | 210021523 | MERCAPTOPURINE |
| 210036811 | 210010255 | 0 | 95 | Disease modification (D) | 2015-05-28 | 2015-06-08 | CHOP R - 21 days | N | N | 210021606 | CHOP R |
| 210036812 | 210010303 | 1.81 | 95.2 | Curative (C) | 2016-07-18 | 2016-07-18 | ALL Int GdeC D Int PhIV reind PAsp | N | N | 210021830 | ALL INTENSIFICATION |
| 210036813 | 210010463 | null | 98 | Curative (C) | 2019-01-04 | 2019-05-04 | ALL ALLR3: HR Indn: Wk 1-4 (PegAsp) | null | N | 210023222 | UKALLR3 |
| 210036814 | 210010469 | 0.99 | 63.5 | Curative (C) | 2016-03-10 | 2016-05-05 | Etoposide IV | Y | null | 210023251 | ETOPOSIDE |
| 210036815 | 210010494 | 0 | 95.4 | Disease modification (D) | 2017-11-18 | 2018-03-04 | Chlorambucil | Y | N | 210023423 | CHLORAMBUCIL |
| 210036818 | 210010697 | 1.64 | 27.1 | Curative (C) | 2016-08-31 | 2016-08-31 | Venetoclax | N | N | 210025775 | VENETOCLAX |
| 210036819 | 210010759 | 1.76 | 86.65 | Curative (C) | 2017-09-13 | 2017-09-14 | Mercaptopurine | N | N | 210026643 | MERCAPTOPURINE |
| 210036820 | 210027281 | 1.71 | 58.9 | Curative (C) | 2017-10-23 | 2017-10-28 | Venetoclax | 01 | N | 210027027 | VENETOCLAX |
| 210036821 | 210010803 | 1.59 | 22 | Curative (C) | 2015-12-05 | 2016-06-23 | ALL Int GdeC D Int PhIV recon Pasp | 02 | N | 210027036 | ALL INTENSIFICATION |
| 210036822 | 210010814 | 1.61 | 93.8 | Adjuvant (A) | 2017-10-13 | 2017-10-14 | Alemtuzumab cond (RI ALLO CAMP100) | 01 | N | 210027099 | ALEMTUZUMAB |
| 210036823 | 210021046 | null | 0 | Curative (C) | 2017-08-05 | 2017-08-06 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | N | N | 210027124 | UKALLR3 |
| 210036824 | 210010853 | 1.46 | 20 | Curative (C) | 2015-07-08 | 2015-07-08 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 02 | N | 210027335 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036825 | 210010866 | 1.75 | 12.6 | Curative (C) | 2020-01-21 | 2020-01-24 | CHOP R | Y | N | 210027506 | CHOP R |
| 210036826 | 210010875 | 1.66 | 77.7 | Curative (C) | 2017-05-02 | 2017-05-14 | Alemtuzumab cond (RI ALLO CAMP100) | 02 | N | 210027529 | ALEMTUZUMAB |
| 210036827 | 210021090 | null | 80 | Curative (C) | 2016-10-23 | 2018-06-26 | Carboplatin AUC 2 - 5 | N | N | 210027745 | CARBOPLATIN |
| 210036828 | 210010924 | 0 | 0 | Disease modification (D) | 2015-04-27 | 2015-04-29 | Chlorambucil | N | Y | 210027813 | CHLORAMBUCIL |
| 210036830 | 210010966 | 1.55 | 80 | Curative (C) | 2016-08-03 | 2016-08-03 | Carboplatin AUC 2 - 5 | N | null | 210027956 | CARBOPLATIN |
| 210036831 | 210010996 | 1.75 | 105 | Curative (C) | 2015-03-04 | 2015-11-01 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 210028034 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036832 | 210011025 | 1.81 | 11.5 | Disease modification (D) | 2018-12-19 | 2019-02-26 | CHOP R - 21 days | N | N | 210028127 | CHOP R |
| 210036833 | 210021151 | null | 81.7 | Curative (C) | 2019-08-12 | 2019-08-15 | ALL ALLR3: S/IR Ind Wk 1-4 (pegAsp) | 1 | N | 210028183 | UKALLR3 |
| 210036834 | 210011093 | null | null | Curative (C) | 2016-07-02 | 2016-09-24 | Alemtuzumab | N | null | 210028382 | ALEMTUZUMAB |
| 210036835 | 210021190 | null | 80 | Disease modification (D) | 2015-09-05 | 2016-04-05 | Chlorambucil | N | N | 210028497 | CHLORAMBUCIL |
| 210036836 | 210011171 | 1.68 | 22.5 | Palliative (P) | 2016-04-21 | 2017-10-10 | CARBOPLATIN | N | N | 210028647 | CARBOPLATIN |
| 210036837 | 210011253 | null | null | Curative (C) | 2016-11-10 | 2018-07-24 | ALL Int Guide A/B/C Maint Ph V | N | Y | 210028901 | ALL INTERIM GUIDELINES |
| 210036838 | 210011303 | 1.85 | 71.3 | Disease modification (D) | 2016-10-28 | 2016-10-28 | FLAG + Idarubicin | N | N | 210029102 | FLAG + IDARUBICIN |
| 210036839 | 210011317 | 0 | 80.8 | Curative (C) | 2015-09-27 | 2016-01-29 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 01 | N | 210029159 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 210036840 | 210011326 | null | 74.5 | null | 2016-09-12 | 2017-05-22 | CHOP R | 1 | N | 210029191 | CHOP R |
| 210036841 | 210011334 | 1.76 | 94 | Curative (C) | 2019-04-15 | 2019-04-15 | BLINATUMOMAB | N | N | 210029196 | BLINATUMOMAB |
| 210036842 | 210011364 | 1.64 | 66 | null | 2015-06-15 | 2018-07-14 | ALL Int Gde A/B DInt PhIV pt1 PAsp | Y | N | 210029291 | ALL INTENSIFICATION |
| 210036843 | 210011490 | null | null | Curative (C) | 2017-09-02 | 2018-08-28 | Blinatumomab | Y | N | 210029804 | BLINATUMOMAB |